Katie Jennings is a senior writer covering healthcare and AI. Pear’s stock closed at 39 cents a share on Friday, down 34% from 59 cents at yesterday’s close. The Boston-based company had raised $250 ...

Since Pear Therapeutics, one of the earliest digital therapeutic companies, declared bankruptcy in April, there's been discussion surrounding the state of investments in digital therapeutics, ...

Figuring out the best user experience can be a tricky process for any platform. But its particularly important in digital therapeutics, which some view as a disruptor to traditional pharmaceuticals.

A sixth-generation pear grower discusses the challenges California pear growers face due to imports, affecting the market.